PMS26 Cost-Effectiveness of Denosumab Versus Oral Bisphosphonates in the United States for Post-Menopausal Osteoporosis (PMO)

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.215
https://www.valueinhealthjournal.com/article/S1098-3015(12)00280-X/fulltext
Title : PMS26 Cost-Effectiveness of Denosumab Versus Oral Bisphosphonates in the United States for Post-Menopausal Osteoporosis (PMO)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00280-X&doi=10.1016/j.jval.2012.03.215
First page : A38
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 985
Categories :
Tags :
Regions :
ViH Article Tags :